Analytical Evaluation of the Endotest® Diagnostic

NANot yet recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

October 31, 2023

Primary Completion Date

January 31, 2024

Study Completion Date

January 31, 2024

Conditions
EndometriosisDiagnosis
Interventions
DEVICE

Salivary Sampling

"Inclusion visit: After signature of the informed consent, all subjects will perform 3 consecutive Endotest® Diagnostic during the visit and 1 at-home.~Circadian circle visit: 6 included subjects will be asked to come back for a full day. They will have to perform 17 Endotest® Diagnostic: 14 on study site and 3 at home after the visit.~Repeatability-intermediate fidelity-stability-interferences visit: a maximum of 16 included subjects will be asked to come back for this visit. They will have to perform 17 Endotest® Diagnostic: 14 on study site and 3 at home after the visit."

Trial Locations (2)

33000

Clinique Tivoli, Bordeaux

76000

CHU de Rouen, Rouen

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Monitoring Force Group

INDUSTRY

lead

ZIWIG

INDUSTRY